Analysis: Stocks

Colonial SFL: Still healthy

Earnings/Sales releases Colonial SFL continues to perform well in an end market in France that keeps deteriorating. The Spanish market is performing very well. Fact Like-for-like revenue growth was...

Metso Corporation: Decent Q226 results and a positive order intake surprise

Earnings/Sales ReleasesMetso's Q226 results showed a 6% year-on-year revenue increase to €1,334m and a 21% rise in adjusted EBITA to €221m, though profitability was slightly below consensus at the...

DENSO's Growth Ambitions Face Execution Test

Demand remains intact - and strong - but the market is asking tougher questions.

Nexity: The market rebound is slow to materialize.

Earnings/Sales releases Revenue and bookings are down in the second quarter of 2026. The anticipated market rebound has yet to materialize. Nexity reiterates that its turnaround plan is sufficient to...

Can DFM Capitalize on Dubai's Financial Ambitions?

Dubai Financial Market PJSC continues to attract investors, although the stock still mirrors investor caution. ...

Banco De Sabadell: So far, so good

Earnings/Sales releases The second-quarter underlying performance was fully in line with expectations, thereby enabling the new CEO to confirm the group's RoTE objectives for 2026 and 2027. Following...

Nestlé: Nestlé is turning despite surface turbulence

Latest Nestlé's trading session experienced a nearly 8% decline yesterday, which appeared excessive. The primary concern was the lack of H2 margin acceleration. However, the overall investment case...

Acerinox: Nice Q226. The valuation is demanding though.

Earnings/Sales releases Acerinox's Q226 valuation appears demanding despite strong H1 results. The company reported an EBITDA of €271m, surpassing consensus by approximately €20m. This performance...

Carrefour: A mixed H1; hypermarket CMD could be the next catalyst

Earnings/Sales releases Carrefour reported a mixed H1 FY26 performance, with Q2 lfl sales beating expectations but recurring operating income modestly missing consensus. Management reiterated...

Leonteq AG: H1-26: Embracing Growth

Earnings/Sales releases H1-26 confirmed Leonteq’s profitability rebound, beating pre-tax consensus with a +10% fee income growth and a healthier revenue mix, validating that earnings troughed in...

SAP: The Giant's nap will outlast the SaaS Apocalypse hype

Earnings/Sales releasesSentiment says apocalypse; the numbers say otherwise. SAP again delivers above-expectation cloud growth, proof its shift to the “Autonomous Enterprise” and Business AI is...

The Bug in Your Ear: Cybersecurity Runs Into AI

Since 2022, the rise of generative artificial intelligence has upended the rules of cybersecurity. With attackers now equipped with AI, companies and security software vendors are accelerating their...

Nokia: AI infrastructure demand drives strong growth as optical networks scale up

Significant news Nokia delivered strong Q2 2026 results as AI and cloud infrastructure demand accelerated. Sales grew by 9%, supported by Network Infrastructure, where optical and IP networks...

UPM-Kymmene: Disappointing Q2 despite somewhat exceeding street profit expectations

Earnings/Sales releases Markets have strongly disapproved of UPM's Q2 results, despite profit metrics coming slightly ahead of street expectations. Pulp had a mixed quarter, while Energy was...

Beat on operating result from activity, not sales

Earnings/sales releases Organic sales weakened in Q2 2026 after a moderate Q1. While Consumer met expectations, the Professional business disappointed with a decrease in organic sales. The operating...

Givaudan: Givaudan H1: Sales beat, cash flow is the sore point

Earnings/Sales releases Givaudan's performance in the first half of the year was mixed. Revenue surpassed expectations, driven by strong results in the Fragrance & Beauty segment and a resilient Fine...

Valeo: Strong H1, Margin and FCF Beat, Guidance Confirmed Amid Positive China Momentum

Earnings/Sales releases Valeo reported strong H1 results, exceeding expectations in operating margin, primarily due to margin upswing in the Power division. Light and Brain divisions outperformed...

Eurofins Scientific: BioPharma's slowdown raises questions on 2026 organic growth target

Earnings/sales releases Eurofins' H1 results were in line with expectations on revenues but ahead of them on adjusted EBITDA. Organic Growth improved sequentially with resilient growth in Life and...

Roche Holding: Good Q2; late-stage pipeline execution key to sustained re-rating

Earnings/Sales releasesDespite FX headwinds, the Q2 results were ahead of the street's expectations. The performance was driven by drugs across therapeutic areas, and the Diagnostics business also...